commensurate
发表于 2025-3-30 10:16:21
http://reply.papertrans.cn/16/1586/158531/158531_51.png
PANEL
发表于 2025-3-30 12:36:36
http://reply.papertrans.cn/16/1586/158531/158531_52.png
喊叫
发表于 2025-3-30 19:48:20
Impact, Diagnosis, Phenomenology, and Biology,particularly emphasizes the historical evolution of the pertinent diagnostic constructs and the prognostic import both of the various diagnostic groupings and of the individual symptoms and symptom clusters.
enmesh
发表于 2025-3-31 00:44:07
http://reply.papertrans.cn/16/1586/158531/158531_54.png
无能力之人
发表于 2025-3-31 01:44:12
Pharmacogenomics and Biomarkers of Depression,ion of one antidepressant over another. Among all currently available biomarkers, C-reactive protein (CRP) appears to be the most promising and pragmatic choice. Low CRP (<1 mg/L) in patients with MDD predicts better response to escitalopram while higher levels are associated with better response to
植物茂盛
发表于 2025-3-31 06:43:44
http://reply.papertrans.cn/16/1586/158531/158531_56.png
nugatory
发表于 2025-3-31 12:22:42
http://reply.papertrans.cn/16/1586/158531/158531_57.png
FLUSH
发表于 2025-3-31 14:58:48
Neurostimulation Therapies,ly three such treatments are currently approved by the United States Food and Drug Administration (FDA) for the treatment of major depressive disorder: electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), and repetitive transcranial magnetic stimulation (rTMS). Additionally, numerous othe
避开
发表于 2025-3-31 18:41:27
Current Role of Herbal and Natural Preparations,e treatments remain unanswered and much work needs to be done before we determine their place in the psychiatric armamentarium, we believe that this chapter will give psychiatrists a good perspective on the pros and cons of herbal and natural antidepressants as part of the pharmacological armamentar
友好
发表于 2025-3-31 22:27:50
Role of Inflammation in Depression and Treatment Implications,ional antidepressant therapies. Recent developments in our ability to understand and measure the effects of inflammation on the brain in patients have opened new doors for the testing of novel treatment strategies that target the immune system or its consequences on neurotransmitter systems. Such re